PALISADE BIO, INC. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Palisade Bio, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2024.
  • Palisade Bio, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 280M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 280M 0 0% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 280M 0 0% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 280M 0 0% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 280M 0 0% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 280M -20M -6.67% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 280M -20M -6.67% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 280M -20M -6.67% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 280M -20M -6.67% Dec 31, 2022 10-K 2024-03-26
Q3 2022 300M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 300M 0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 300M 0 0% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 300M +293M +4313% Dec 31, 2021 10-K 2023-03-22
Q3 2021 300M 0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 300M 0 0% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 300M 0 0% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 6.8M -293M -97.7% Dec 31, 2020 10-K 2022-03-17
Q3 2020 300M 0 0% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 300M 0 0% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 300M 0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 300M 0 0% Dec 31, 2019 10-K 2021-03-22
Q3 2019 300M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 300M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 300M 0 0% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 300M 0 0% Dec 31, 2018 10-K 2020-03-27
Q3 2018 300M 0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 300M 0 0% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 300M 0 0% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 300M 0 0% Dec 31, 2017 10-K 2019-03-22
Q3 2017 300M 0 0% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 300M 0 0% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 300M 0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 300M 0 0% Dec 31, 2016 10-K 2018-04-02
Q3 2016 300M 0 0% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 300M 0 0% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 300M 0 0% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 300M 0 0% Dec 31, 2015 10-K 2017-03-23
Q3 2015 300M 0 0% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 300M 0 0% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 300M +150M +100% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 300M 0 0% Dec 31, 2014 10-K 2016-03-14
Q3 2014 300M +150M +100% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 300M +150M +100% Jun 30, 2014 10-Q 2014-11-07
Q1 2014 150M 0 0% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 300M +150M +100% Dec 31, 2013 10-K 2015-03-16
Q3 2013 150M 0 0% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 150M 0 0% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 150M 0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 150M 0 0% Dec 31, 2012 10-K 2014-03-10
Q3 2012 150M 0 0% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 150M 0 0% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 150M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 150M 0 0% Dec 31, 2011 10-K 2013-03-15
Q3 2011 150M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 150M Jun 30, 2011 10-Q/A 2011-09-23
Q4 2010 150M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.